Suzuki, R., Kikuchi, S., Harada, T., Mimura, N., Minami, J., Ohguchi, H., . . . Anderson, K. C. (2015). Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells. PLoS One.
Citación estilo ChicagoSuzuki, Rikio, et al. "Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells." PLoS One 2015.
Cita MLASuzuki, Rikio, et al. "Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells." PLoS One 2015.
Precaución: Estas citas no son 100% exactas.